WO2007093830A1 - Application cutanée - Google Patents
Application cutanée Download PDFInfo
- Publication number
- WO2007093830A1 WO2007093830A1 PCT/GB2007/050066 GB2007050066W WO2007093830A1 WO 2007093830 A1 WO2007093830 A1 WO 2007093830A1 GB 2007050066 W GB2007050066 W GB 2007050066W WO 2007093830 A1 WO2007093830 A1 WO 2007093830A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- application
- irritant
- vitamin
- free skin
- range
- Prior art date
Links
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 18
- 239000004115 Sodium Silicate Substances 0.000 claims abstract description 18
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 18
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052911 sodium silicate Inorganic materials 0.000 claims abstract description 18
- 239000010497 wheat germ oil Substances 0.000 claims abstract description 18
- 239000002085 irritant Substances 0.000 claims abstract description 14
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 14
- 231100000021 irritant Toxicity 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 38
- 239000006071 cream Substances 0.000 claims description 29
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 23
- 229940087603 grape seed extract Drugs 0.000 claims description 22
- 235000002532 grape seed extract Nutrition 0.000 claims description 22
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 22
- 229930003427 Vitamin E Natural products 0.000 claims description 19
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 19
- 235000019165 vitamin E Nutrition 0.000 claims description 19
- 229940046009 vitamin E Drugs 0.000 claims description 19
- 239000011709 vitamin E Substances 0.000 claims description 19
- 244000144927 Aloe barbadensis Species 0.000 claims description 17
- 235000019482 Palm oil Nutrition 0.000 claims description 17
- 239000002540 palm oil Substances 0.000 claims description 17
- 101000709114 Homo sapiens SAFB-like transcription modulator Proteins 0.000 claims description 16
- 102100032664 SAFB-like transcription modulator Human genes 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 12
- 235000019198 oils Nutrition 0.000 claims description 12
- 239000003755 preservative agent Substances 0.000 claims description 10
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000004753 textile Substances 0.000 claims description 6
- 206010013786 Dry skin Diseases 0.000 claims description 5
- 230000037336 dry skin Effects 0.000 claims description 5
- 241000221095 Simmondsia Species 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 14
- 229930003268 Vitamin C Natural products 0.000 claims 14
- 235000011187 glycerol Nutrition 0.000 claims 14
- 235000019154 vitamin C Nutrition 0.000 claims 14
- 239000011718 vitamin C Substances 0.000 claims 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 13
- 229940075529 glyceryl stearate Drugs 0.000 claims 13
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 7
- 229930003571 Vitamin B5 Natural products 0.000 claims 7
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 7
- 229960002079 calcium pantothenate Drugs 0.000 claims 7
- 239000010374 citricidal Substances 0.000 claims 7
- 235000009492 vitamin B5 Nutrition 0.000 claims 7
- 239000011675 vitamin B5 Substances 0.000 claims 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 6
- 235000019155 vitamin A Nutrition 0.000 claims 6
- 239000011719 vitamin A Substances 0.000 claims 6
- 229940045997 vitamin a Drugs 0.000 claims 6
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 claims 5
- 241001071905 Echium Species 0.000 claims 4
- 235000019486 Sunflower oil Nutrition 0.000 claims 4
- 235000021302 avocado oil Nutrition 0.000 claims 4
- 239000008163 avocado oil Substances 0.000 claims 4
- 239000002600 sunflower oil Substances 0.000 claims 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 3
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims 3
- 229940108325 retinyl palmitate Drugs 0.000 claims 3
- 235000019172 retinyl palmitate Nutrition 0.000 claims 3
- 239000011769 retinyl palmitate Substances 0.000 claims 3
- 229940042585 tocopherol acetate Drugs 0.000 claims 3
- 230000001815 facial effect Effects 0.000 claims 2
- 239000008269 hand cream Substances 0.000 claims 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims 1
- 235000009120 camo Nutrition 0.000 claims 1
- 235000005607 chanvre indien Nutrition 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 239000011487 hemp Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 244000186892 Aloe vera Species 0.000 abstract 1
- 229940057995 liquid paraffin Drugs 0.000 description 14
- 239000000126 substance Substances 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002884 skin cream Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000711 cancerogenic effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 231100000051 skin sensitiser Toxicity 0.000 description 3
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- 235000011624 Agave sisalana Nutrition 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 208000020312 Thickened skin Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960002242 chlorocresol Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940113174 imidurea Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- -1 jojoba oil Substances 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940096792 quaternium-15 Drugs 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical group [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Definitions
- This invention relates to skin creams and lotions and in particular to skin creams and lotions that do not contain liquid paraffin or other skin sensitizers.
- Liquid paraffin or mineral oil is widely using in cosmetics as a moisturising agent and emulsifying agent. It is also widely used in creams and lotions in the pharmaceutical industry for both its moisturising and emulsifying properties.
- Liquid paraffin is a by-product derived from crude oil. When used on the skin it inhibits the skin's ability to breathe and exchange moisture with the atmosphere, thereby disrupting the skin's natural immune barrier. Liquid paraffin also blocks skin pores and impedes the skin's ability to eliminate toxins. This has been shown to cause folliculitis and can promote acne and other skin disorders. Liquid paraffin also restricts the ability of the skin to perform its usual function of excreting and absorbing substances. Restriction of this process slows down the skin function and normal cell development causing the skin to prematurely age.
- PAHs Polycyclic Aromatic Hydrocarbons
- liquid paraffin is a derivative of oil, which is becoming increasingly more expensive to produce and is gradually becoming a rare commodity, so alternatives to liquid paraffin will need to be found.
- Hydroxybenzoates (also known as parabens) are routinely used as preservatives.
- Polysorbates are routinely used as emulsifiers. These can be contaminated with dioxane which is known to have carcinogenic effects in rodents.
- Triethanolamine is routinely used as a pH adjuster and emulsifying agent in creams and cosmetics. Triethanolamine is known to cause allergic reactions including eye problems and dry skin and also has been shown to have carcinogenic activity in rats.
- Lanolin is routinely used in creams and cosmetics. Lanolin is produced by wool- bearing animals such as sheep can be contaminated with chemicals used on the animals such as pesticides and insecticides.
- fragrances used in creams and cosmetics are known to have toxic or carcinogenic effects.
- Imidazolidinyl urea is routinely used as a preservative. This compound is associated with adverse skin reactions and has been shown to cause cancer in laboratory animals.
- Butylated hydroxyanisole is an anti oxidant routinely used as a preservative in cosmetic formulations. This compound is a known allergen and has been shown to cause cancerous tumours in test animals.
- Sorbic acid and its derivatives are routinely used as preservatives. These compounds are known irritants and skin sensitizers.
- the present invention is concerned with skin creams and lotions that do not contain liquid paraffin or any compounds that are known to be skin irritants.
- low concentrations of sodium silicate in combination with a range of natural oils have been found to provide excellent emulsifying properties in compositions for application to the skin.
- One aspect of the invention provides an irritant- free skin application as specified in Claim 1
- a second aspect of the invention provides a skin cleansing wipe as specified in Claim 64.
- the invention also relates to methods of reducing wrinkles, methods of delaying the onset of ageing and methods of moisturising skin.
- Skin applications include but are not limited to creams, lotions and sprays.
- the ingredients in all the skin applications of the invention are all not known to be skin irritants, rendering the creams irritant-free.
- skin irritants to include any additive known to cause skin sensitisation or skin irritation, including liquid paraffin, chemical fragrances, hydroxybenzoates (parabens), polysorbates, triethanolamine, lanolin, imidazolidinyl urea, butylated hydroxyaisole, sorbic acid, beeswax, benzyl alcohol, butylated hydroxytoluene, cetostearyl alcohol, chlorocresol, chlorhexidine, edetic acid, ethylenediamine, N-(3-Chloroallyl)hexaminium chloride (quaternium 15), phenoxyethanol, propylene glycol, sodium metabisulphte, triclosan, para-anisyl alcohol, benzyl benzoate, benz
- the irritant-free skin applications of the invention comprise the natural oils jojoba, wheatgerm and palm oil, in significant amounts.
- jojoba oil mimics that of sebum oil which is produced naturally by the skin. This allows the oil to be very easily absorbed by the skin.
- Wheatgerm oil is rich in vitamin E and acts as a natural preservative. It is very good for dry skin as it can relive itching and dryness.
- Palm oil is extracted from oil palm trees. It is a natural source of beta-carotene and vitamin E.
- Aloe vera gel is extracted from the leaf of the aloe vera plant. Aloe vera has well known healing and soothing properties.
- Sodium silicate acts as both an emulsifier, and also provides an exfoliating action, which removes layers of thickened skin, thereby allowing the moisturising oils in the skin application to penetrate the skin more easily.
- Alkoline SLTM and Alkoline GCTM are both non-irritant, naturally derived emulsifiers supplied by Karlshamns AB.
- Alkoline SLTM is Sodium stearoyl lactylate
- Alkoline GCTM is Hydrogenated vegetable glycerides citrate.
- Non-irritant preservatives include salicyclic acid and grapeseed extract.
- Salicyclic acid is not recommended for use in products for young children.
- Grapeseed extract is the preferred preservative for skin applications intended for young children.
- the resulting skin application is a smooth low viscosity cream or lotion which is less occlusive in nature compared to compositions comprising liquid paraffin, thereby allowing the skin to Tareathe' more easily.
- Creams and lotions have excellent moisturising effects and produce minimal irritation.
- the skin applications of the invention can also be impregnated onto a textile to form a baby wipe or cleansing wipe.
- a textile is biodegradable and may be derived from hemp plant fibres or other similar plant fibres.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Application cutanée non irritante comprenant au moins un émulsifiant non irritant ; de l'huile de jojoba en une quantité de 3 à 7% ; de l'huile de germes de blé en une quantité de 2 à 5% ; de l'Aloe vera en une quantité de 2,5 à 7 % ; et du silicate de sodium en une quantité de 0,001 à 0,003% ; toutes les quantités étant exprimées en poids.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07705379A EP1986593A1 (fr) | 2006-02-17 | 2007-02-15 | Application cutanee |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0603167.8 | 2006-02-17 | ||
GBGB0603167.8A GB0603167D0 (en) | 2006-02-17 | 2006-02-17 | Skin application |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007093830A1 true WO2007093830A1 (fr) | 2007-08-23 |
Family
ID=36141981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/050066 WO2007093830A1 (fr) | 2006-02-17 | 2007-02-15 | Application cutanée |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1986593A1 (fr) |
GB (2) | GB0603167D0 (fr) |
WO (1) | WO2007093830A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2468127A (en) * | 2009-02-25 | 2010-09-01 | Ajit Lalvani | Cosmetic or pharmaceutical preparation for the skin |
ES2393028A1 (es) * | 2011-03-24 | 2012-12-17 | Martín BAENA JIMÉNEZ | Procedimiento de obtención de una crema de manos. |
ES2395011A1 (es) * | 2011-03-25 | 2013-02-07 | Martín BAENA JIMÉNEZ | Procedimiento de obtención de una leche corporal |
CN103040700A (zh) * | 2012-12-14 | 2013-04-17 | 吴江市德佐日用化学品有限公司 | 一种护手霜的制备方法 |
ES2562085A1 (es) * | 2014-09-02 | 2016-03-02 | Amedyn Healthcare, S.L. | Crema para el tratamiento de pieles con estados descamativos y procedimiento de fabricación de dicha crema |
WO2016206770A1 (fr) * | 2015-06-23 | 2016-12-29 | Lalvani, Ajit | Préparation cosmétique ou pharmaceutique pour régulation de fibrilline |
US9855203B2 (en) | 2013-06-27 | 2018-01-02 | The Procter & Gamble Company | Preserving personal care compositions |
GB2604653A (en) * | 2021-03-12 | 2022-09-14 | Ubeauty Global | A tanning composition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2529809C1 (ru) * | 2013-10-21 | 2014-09-27 | Открытое акционерное общество "Новосибхимфарм" | Детский крем для ежедневного ухода с пантенолом |
CN108403575A (zh) * | 2018-06-11 | 2018-08-17 | 广州三亮科技有限公司 | 一种婴宝护肤膏 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998038977A1 (fr) * | 1997-03-05 | 1998-09-11 | Pentapharm Ag | Combinaison d'erythrulose et d'un sucre reducteur presentant un effet autobronzant |
WO2005084619A1 (fr) * | 2004-03-08 | 2005-09-15 | Dermasalve Limited | Composition contenant du silicate de sodium destinee a etre utilisee dans le traitement de conditions de peau seche |
-
2006
- 2006-02-17 GB GBGB0603167.8A patent/GB0603167D0/en not_active Ceased
-
2007
- 2007-02-15 GB GB0702931A patent/GB2437150A/en not_active Withdrawn
- 2007-02-15 WO PCT/GB2007/050066 patent/WO2007093830A1/fr active Application Filing
- 2007-02-15 EP EP07705379A patent/EP1986593A1/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998038977A1 (fr) * | 1997-03-05 | 1998-09-11 | Pentapharm Ag | Combinaison d'erythrulose et d'un sucre reducteur presentant un effet autobronzant |
WO2005084619A1 (fr) * | 2004-03-08 | 2005-09-15 | Dermasalve Limited | Composition contenant du silicate de sodium destinee a etre utilisee dans le traitement de conditions de peau seche |
Non-Patent Citations (5)
Title |
---|
AARHUS-KARLSHAMN SWEDEN AB: "ALKOLINE GC", NATURAL VEGETABLE FUNCTIONAL, THE LIPID EXPERT, January 2006 (2006-01-01), XP002441055, Retrieved from the Internet <URL:http://www.aak.com/upload/akoline_gc_0601.pdf> [retrieved on 20070704] * |
AARHUS-KARLSHAMN SWEDEN AB: "ALKOLINE SL", NATURAL VEGETABLE FUNCTIONAL, THE LIPID EXPERT, January 2006 (2006-01-01), XP002441054, Retrieved from the Internet <URL:http://www.aak.com/upload/akoline_sl_0601.pdf> [retrieved on 20070704] * |
AARHUS-KARLSHAMN SWEDEN AB: "Emulsifiers that taste good - ALKOLINE", NATURAL VEGETABLE FUNCTIONAL, THE LIPID EXPERT, 8 October 2005 (2005-10-08), XP002441053, Retrieved from the Internet <URL:http://www.aak.com/upload/Akoline_emulsifier.pdf> [retrieved on 20070704] * |
ECO VOICE: "Natural Living", ECO E-NEWS, September 2005 (2005-09-01), XP002441056, Retrieved from the Internet <URL:http://www.ecovoice.com.au/evonline/evo-23/evo23-decodingcosmetics.html> [retrieved on 20070705] * |
LAPINSKAS P: "VIPER'S BUGLOSS & PURPLE VIPER'S BUGLOSS (ECHIUM)", 27 September 2002 (2002-09-27), XP002441057, Retrieved from the Internet <URL:http://www.ienica.net/crops/echium.pdf> [retrieved on 20070705] * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2468127A (en) * | 2009-02-25 | 2010-09-01 | Ajit Lalvani | Cosmetic or pharmaceutical preparation for the skin |
ES2393028A1 (es) * | 2011-03-24 | 2012-12-17 | Martín BAENA JIMÉNEZ | Procedimiento de obtención de una crema de manos. |
ES2395011A1 (es) * | 2011-03-25 | 2013-02-07 | Martín BAENA JIMÉNEZ | Procedimiento de obtención de una leche corporal |
CN103040700A (zh) * | 2012-12-14 | 2013-04-17 | 吴江市德佐日用化学品有限公司 | 一种护手霜的制备方法 |
US9855203B2 (en) | 2013-06-27 | 2018-01-02 | The Procter & Gamble Company | Preserving personal care compositions |
ES2562085A1 (es) * | 2014-09-02 | 2016-03-02 | Amedyn Healthcare, S.L. | Crema para el tratamiento de pieles con estados descamativos y procedimiento de fabricación de dicha crema |
WO2016206770A1 (fr) * | 2015-06-23 | 2016-12-29 | Lalvani, Ajit | Préparation cosmétique ou pharmaceutique pour régulation de fibrilline |
GB2604653A (en) * | 2021-03-12 | 2022-09-14 | Ubeauty Global | A tanning composition |
Also Published As
Publication number | Publication date |
---|---|
GB0702931D0 (en) | 2007-03-28 |
GB2437150A (en) | 2007-10-17 |
GB0603167D0 (en) | 2006-03-29 |
EP1986593A1 (fr) | 2008-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007093830A1 (fr) | Application cutanée | |
CA2716184C (fr) | Concentres aqueux de 4-hexylresorcinol de grande limpidite | |
US8431170B2 (en) | Antimicrobial composition with low cytotoxicity | |
HU230156B1 (hu) | Hagymakivonatot és zsírolajat tartalmazó szer előállítása károsodott bőrszövet, különösen sebhelyek ellátására, megelőzésére vagy kezelésére | |
WO1999008649A2 (fr) | Creme moussante de soins corporels | |
KR20190142655A (ko) | 7-데하이드로콜레스테롤, 콜레스테롤 및 스테아린산이 히알루론산-세라마이드 엔피 복합체의 내상에 봉입된 나노에멀젼을 함유하는 화장료 조성물 및 그의 제조방법 | |
RU2382635C1 (ru) | Крем для рук | |
WO2004105689A2 (fr) | Composition s'appliquant localement afin de traiter des lesions epidermiques et ses methodes d'utilisation | |
KR101605324B1 (ko) | 각질 제거 및 수분량 증가를 통한 건조 및 가려움 완화 효과를 가지는 보습용 화장료 조성물 | |
WO2021017448A1 (fr) | Composition externe pour la peau destinée à soulager les démangeaisons | |
CA2285012C (fr) | Medicament pour application externe et utilisation d'une emulsion huile dans eau pour ledit medicament | |
CN110755279A (zh) | 一种抗菌皮肤护理用品 | |
RU2663910C1 (ru) | Косметический крем для защиты кожи детей от ветра и непогоды | |
US20090022675A1 (en) | Esters with warming properties | |
US20110002861A1 (en) | Composition comprising pure aloe and its use as a cosmetic base | |
CN105012184A (zh) | 一种用于调理角质肌肤的化妆品组合物 | |
RU2205627C1 (ru) | Крем для лица, выводящий токсины | |
JP6651104B1 (ja) | 外用組成物の生産方法 | |
RU2723483C1 (ru) | Косметический крем для рук | |
AU2020407254B2 (en) | Personal care compositions and methods for the same | |
KR102613485B1 (ko) | 저자극성 천연화장품 및 그의 제조방법 | |
KR102575645B1 (ko) | 여드름 원인균 프로피오니박테리움 아크네스에 대한 항균성 무자극 피부 외용제 조성물 | |
RU2151590C1 (ru) | Крем косметический для рук и ногтей | |
KR20240082798A (ko) | 피부 개선용 화장료 조성물 | |
JP2017519748A (ja) | パーソナルケア組成物におけるオイルフリーエモリエント剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007705379 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008554860 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |